Private Equity FundPuts its own capital into companiesActive · deal in last 18 monthsLAST VERIFIED Oct 2026 · 23 SOURCES

Parquest

Also known as Parquest Capital, PARQUEST CAPITAL

Paris small/mid-market private equity manager (AMF GP02-021) investing €10M–€100M per deal in French SMEs in B2B services, software and health & care; Parquest III closed at €414M in 2024.

HEADQUARTERS: Paris, France
FOUNDED: —
AUM: —
OUTSIDE CAPITAL: Yes
TEAM LISTED: 11 people

Focus

STAGES: Buyout
SECTORS: Software & SaaS HealthTech
ASSET MIX: Private equityDirect investments
GEOGRAPHY: France

Overview

Parquest is an independent Paris-based private equity manager that invests in French SMEs through family successions, primary and secondary MBOs, carve-outs of non-core subsidiaries and equity reinforcements, investing €10M to €100M per transaction as majority or minority shareholder. It favours three sectors: B2B services, software, and health & care, and reports 40 investments and 96 add-on acquisitions. In June 2024 it closed its third fund, Parquest III, at €414M, above its €400M target and up from €310M for the previous fund. Recent investments include Betem Groupe (October 2025), Spectrum Groupe (2025), Vitalliance and Amelkis (2024).

Investment thesis

Backs French SMEs valued between €20M and €200M with expansion potential in France and abroad, mainly in B2B services, software and health & care; Parquest III targets about a dozen companies with tickets up to €100M including co-investment.

PORTFOLIO (12)

ADITNOTABLE
since 2019
UnitherNOTABLE
HealthTech · since 2006
Betem Groupe
Industrial & Manufacturing · since 2025
Spectrum Groupe
Software & SaaS · since 2025
Vitalliance
HealthTech · since 2024
Amelkis
Software & SaaS · since 2024
Imaneo
HealthTech · since 2023
Xelya
Software & SaaS · since 2023
Advens
Software & SaaS · since 2021
Tediber
Consumer & E-commerce · since 2021
Epikure
Food & Agriculture · since 2021
Allen
since 2021 · Exited (2025)

People

Pierre Decré
Directeur Associé (President of Parquest III governance) · source
Denis Le Chevallier
Directeur Associé · source
Vincent Warlop
Directeur Associé · source
Thomas Babinet
Directeur Associé · source
Laurence Bouttier
Directrice Associée · source
Camille Coutelet
Directeur Associé · source
Guillaume Brian
Directeur Associé · source
Muriel D’Ambrosio
Directrice Associée, Relations Investisseurs · source
Gabriela Sepulchre
Secrétaire Générale · source
Paul Boursier
Operating Partner, Finance & Buy-and-Build · source
Blandine Surry
Operating Partner, ESG · source

Frequently asked questions

Parquest is a private equity fund based in Paris, France.

Yes. Parquest invests its own capital in private companies.

Parquest invests at Buyout stage in Software & SaaS and HealthTech.

Parquest's stated ticket size is €10M–€100M.

Key people at Parquest include Pierre Decré (Directeur Associé (President of Parquest III governance)), Denis Le Chevallier (Directeur Associé), Vincent Warlop (Directeur Associé) and Thomas Babinet (Directeur Associé).

Parquest's investments include ADIT, Unither, Betem Groupe, Spectrum Groupe, Vitalliance, Amelkis, Imaneo and Xelya, among others.

The most recent publicly reported investment by Parquest is Betem Groupe (Minority MBO alongside management), announced in Oct 2025.

Yes. Parquest manages capital from outside investors.